although the exact risk of amsa causing additional cardiac damage will require more extensive experience , this case suggests that amsa may be safely given to patients with anthracycline cardiomyopathy and may be the treatment of choice for this group of patients .
C0018787
cardiac
C0878544
cardiomyopathy